Capsule is disrupting the $425 billion pharmacy industry through a blend of innovative technology and an emotionally compelling brand. The company's focus on personalized outcomes for doctors, hospitals, insurers, and manufacturers sets it apart in the healthcare sector. Founded in 2016 in the United States, Capsule has secured a significant $500MM in funding from prominent healthcare and technology investors. Its most recent $300.00M Series D investment in April 28, 2021 was led by a consortium including T. Rowe Price, Baillie Gifford, Durable Capital Partners, Whale Rock Capital Management, IPD Capital, LLC. Capsule's commitment to human-centric care is evident in its overarching philosophy, which prioritizes the well-being of both its customers and internal team.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series D | $300.00M | 5 |
|
28 Apr 2021 |
| Series C | $200.00M | 5 |
|
13 Sep 2019 |
| Series B | $50.00M | - | 09 Aug 2018 | |
| Series A | $20.00M | - | 10 May 2017 | |
| Series A | Unknown | - | 14 Oct 2016 |
No recent news or press coverage available for Capsule.
We care about your data, and we'd love to use cookies make your experience better.
